PROFFESSIONAL HISTORY
- Feb 2020 - today: Associate director of the 2nd Haematology clinic, Metropolitan Hospital, Piraeus
- 2019: “Excellence in thrombosis” certification by the “institute for studying & educating about thrombosis and antithrombotic treatment”
- 2017 - today: Volunteer haematologist in Ag.Stefanos’ social clinic.
- 2015 - today: Reviewer for “Blood coagulation and fibrinolysis” journal
- May 2013 - Jan 2020: Haematology consultant for Mediterraneo Hospital, Glyfada, Greece. In charge of haemostasis department/outpatient clinic
- May 2013 - today: Collaborating with the haemostasis group of “Tenon” university hospital, Paris, France in patient management, studies, congress presentations etc.
- 2011 - 2012: “Stage de perfectionnement” in haemostasis as an intern, at the “Service d’ Hematologie biologique”, Tenon Hospital Paris (Université Pierre et Marie Curie, Paris VI), France
- 2010 - 2013: Registrar MD specialising in Haematology in the Haematology Clinic of “Metaxa” Specialised Anti-Cancer Hospital of Piraeus
- 2008 - 2010: Registrar MD specialising in Haematology in the Haematologic department and the Transfusion Centre of “Aghios Panteleimon” General Hospital of Nikea, Piraeus
- 2008 - 2008: Volunteer External Scientific Partner for the Haematology clinic of the “Amalia Fleming” General Hospital of Melissia
- 2006 - 2008: Registrar MD specialising in Internal Medicine in the 1st Internal Medicine Clinic of the “Amalia Fleming” General Hospital of Melissia.
- 2005 - 2006: SHO residency in internal medicine, general surgery and cardiology at Thebes General Hospital in preparation of the rural medical service and Rural Medical Service at the regional medical station of Pili of Schimatari’s health centre of Thiva’s General Hospital
EDUCATION
- 2001 - today Presence in medical seminars & congresses
- 2008 Issued a Licence to teach English in foreign language schools, by the Secondary Education Office
- 2003 Recognition of Medical Degree by the Interuniversitary Centre for Recognising Foreign Study Diplomas (DI.K.A.T.S.A) after successfully taking exams in the fields of Internal Medicine & Surgery
- 2001: Medical Degree from the University of Medicine and Pharmacy “Gr. T. Popa”, Iasi-Romania (English language department)
- 1995: Highschool Diploma by the General Highschool of Drossia
- 1994: Awarded the “Cambridge Certificate Of Proficiency In English”
SPOKEN LANGUAGES
- Greek: Fluent (native)
- English: Fluent
- Romanian: Fluent
- French: Limited working proficiency
SCIENTIFIC WORK
- 8th Educational Vascular Conference “Prevention - Treatment - Complications of Thromboembolic Disease in the 21st Century” Athens, January 25th 2020, Grand Amphitheater of “Sotiria” hospital, Athens, Greece
- 7th Interactive Educational Vascular Conference “Venous Thromboembolic Disease versus Effective Treatment. Are you ready?" Athens, 19th of January 2019, Grand Amphitheater of “Sotiria” hospital, Athens, Greece
- Prospective Assessment of Clinical Risk Factors and Biomarkers of Hypercoagulability for the Identification of Patients with Lung Adenocarcinoma at Risk for Cancer - Associated Thrombosis: The Observational ROADMAP - CAT Study. Oncologist. 2018 Aug 13. pii: theoncologist.2017-0530. doi: 10.1634/theoncologist.2017-0530. [Epub ahead of print]
Syrigos K, Grapsa D, Sangare R, Evmorfiadis I, Larsen AK, Van Dreden P, Boura P, Charpidou A, Kotteas E, Sergentanis TN, Elalamy I, Falanga A, Gerotziafas GT. - 3rd educational symposium of the 1st ICU Clinic of Athens’ university of medicine. Dealing with Respiratory Problems in the Community: Thrombophilia testing after thromboembolic event and the effect of its results on treatment. May 18th-19th 2018, Athens, Greece, Doma Amphitheater, "Evangelismos" general hospital
- 5th Winter School of Thrombosis - Antithrombotic Education: Understanding the Data of Clinical Studies and Their Impact on Clinical Practice: Co-administration of Antiplatelets and DOACs. Latest data
- 5th Panhellenic Conference on Thrombosis - Antithrombotic Education: Facts and gaps in the treatment of thromboembolic venous disease in patients with multiple myeloma. September 21st-23rd, 2017, Egli Zappeiou, Athens, Greece
- ANCA-Negative Churg-Strauss Syndrome Presenting as Acute Multiple Cerebral Infarcts: A Case Report. Journal of Stroke and Cerebrovascular diseases
Klearchos Psychogios, MD1, Ilias Evmorfiadis, MD2, Spyros Dragomanovits, MD3, Athanasios Stavridis, MD1, Konstantinos Takis, MD1, Loukas Kaklamanis, MD4, and Stathis Pantelis, MD1 - 5th Educational Angiology day conference, grand amphitheater “Sotiria” Hospital 19/11/2016: VTE Treatment in Thrombophilia (Oral presentation)
- American Society of Clinical Oncology annual meet.ing, June 3-7 2016, Chicago, Illinois: Identification of clinical variables and biomarkers of hypercoagulability for VTE risk evaluation in ambulatory patients with lung adenocarcinoma on chemotherapy: The ROADMAP study
Grigoris Gerotziafas, Paraskey Boura, Andriani Charpidou, Ioannis Gkiozos, Ilias Evmorfiadis, Patrick Van Dreden, Aurelie Rousseau, Rabiatou Sangare, Annette K Larsen, Konstantinos N. Syrigos, Ismail Elalamy - American Society of Clinical Oncology annual meeting, June 3-7 2016, Chicago, Illinois: A clinico-biological Risk Assessment Model for VTE in ambulatory patients with lung adenocarcinoma on chemotherapy issued from the ROADMAP study
Grigoris Gerotziafas, Ilias Evmorfiadis, Paraskevi Boura, Patrick Van Dreden, Andriani Charpidou, Aurelie Rousseau, Annette K Larsen, Konstantinos N. Syrigos, Rabiatou Sangare, Ioannis Gkiozos, Ismail Elalamy - 2016 ISTH SSC, Montpellier France, May 25-28: Biomarkers of hypercoagulability and clinical variable related with VTE risk in ambulatory patients with lung adenocarcinoma on chemotherapy. The ROADMAP study
Gerotziafas G1,2, Evmorfiadis I1, Boura P3, Rousseau A4, Charpidou A3, Van Dreden P4, Giozos G3, Grusse M4, Sangate R2, Larsen A2, Syrigos K3 and Elalamy I1,2 - 2016 ISTH SSC, Montpellier France, May 25-28: Development of a new risk assessment model for VTE specific for ambulatory patients with lung adenocarcinoma on chemotherapy. The ROADMAP study
Gerotziafas G1,2, Evmorfiadis I3, Van Dreden P4, Boura P5, Rousseau A4, Charpidou A5, Giozos G5, Grusse M4, Larsen A2, Sangare R2, Syrigos K5 and Elalamy I1,2 - Biennial International Congress on Thrombosis, Istanbul, Turkey - May 4-7, 2016: A NEW RISK ASSESSMENT MODEL FOR VTE IN AMBULATORY PATIENTS WITH LUNG ADENOCARCINOMA ON CHEMOTHERAPY. THE ROADMAP STUDY
Gerotziafas G, Evmorfiadis I, Boura P, Giozos G, Charpidou A, Rousseau
A, Van Dreden P, Grusse M, Annette Larsen, Syrigos K, Ismail Elalamy - Biennial International Congress on Thrombosis, Istanbul, Turkey - May 4-7, 2016: SELECTION OF BIOLOGICAL MARKERS OF HYPERCOAGULABILITY FOR THE IDENTIFICATION OF HIGH VTE RISK PATIENTS WITH LUNG ADENOCARCINOMA. THE ROADMAP STUDY
I. Evmorfiadis, P. Boura, A. Rousseau, A. Charpidou, G. Giozos, P. Van
Dreden, K. Syrigos, A. Larsen, Ismail Elalamy, G. T. Gerotziafas - 8th ICTHIC, April 8-10, 2016 Bergamo, Italy: Prospective evaluation of risk assessment models and biological markers of hypercoagu-lability for the identification of high VTE risk patients with lung adenocarcinoma. The ROADMAP study Thromb Res.
2016 Apr;140 Suppl 1:S196. doi: 10.1016/S0049-3848(16)30186-4. Epub 2016 Apr 8.
P. Boura, I. Evmorfiadis, A. Rousseau, A. Charpidou, G. Giozos, P. Van Dreden, K. Syrigos, A. Larsen, I. Elalamy, G. T. Gerotziafas (Greece, France) - ISTH 2015 Congress, Toronto, June 20-25: Prospective Evaluation of Risk Assessment Models and Biological Markers of Hypercoagulability for the Identification of High VTE Risk Patients With Lung Adenocarcinoma. The ROADMAP Study.
Ilias Evmorfiadis1,2,5, Paraskevi Boura3, Aurélie Rousseau1,2,4, Ariadni Charpidou2, Giannis Giozos2, Patrick Van Dreden4, Konstantinos Syrigos2, Anastasia Spanoudaki5, Matthieu Grusse4, Ismail Elalamy 1,2 and Grigoris T. Gerotziafas1,2
56th American Society of Hematology Annual Meeting and Exposition, San Francisco, CA, 6-9 December 2014: Differential Influence of Lung Cancer Stage, Time from Diagnosis and Chemotherapy on Plasma and Cellular Biomarkers of Hypercoagulability. The ROADMAP Study
Ilias Evmorfiadis1, Paraskevi Boura2, Aurélie Rousseau3,1, Ariadni Charpidou2, Giannis Giozos2, Patrick Van Dreden, PhD4, Konstantinos Syrigos2, Anastasia Spanoudaki5, Matthieu Grusse3, Ismail Elalamy, MD6,5, and Grigorios T. Gerotziafas7,5 - 55th American Society of Hematology Annual Meeting and Exposition, New Orleans 7-10 December 2013: A Synthetic Evaluation Of Genetic and Pharmacological Resistance To Clopidogrel and On Treatment Residual Platelet Aggregation In Patients With Atherothrombosis
Grigoris T Gerotziafas1,2*, Severin Bouffard3*, Patrick Van Dreden, Ph.D.4, Amir Kartechi5*, Ilias Evmorfiadis6*, Marie-Paule Roman3*, Vassiliki Galea3,6*, Dimitra Karipidi6* and Ismail Elalamy, MD7,8* - 2nd Educational Workshop in Angiology, November 16, 2013, Grand Amphitheatre of "Sotiria" hospital, Athens
Thrombophilia treatment
Ilias Evmorfiadis, Gregory Gerotziafas - 8th International Congress on Vascular Dementia & The First Cognitive Impairment European Meeting, Athens, Greece, October 17-20, 2013
Anticoagulant & Antiplatelet Treatment in Dementia Patients, a puzzling question
I.Evmorfiadis1, N.G. Tsamopoulos2, G.T. Gerotziafas3 - Publication on «Haema» October – December 2011, Vol. 2-Issue 4, notices for publication:
Massive lymphadenopathy due to Castleman’s disease: Four case-presentations
I. Evmorfiadis1, I. Patsias1, Α. Konstantinou1, Μ. Plega1, Μ. Stamouli1, Κ. Galani2, Κ. Ntatsis3, Ι. Iakovidou2, E. Megalakaki1 - Publication on «Haema» – December 2011, Vol. 2-Issue 4, notices for publication:
Immunoglobulin levels and infections in Multiple Myeloma patients, on two different Bortezomib-based chemotherapeutic groups
Α. Konstantinou1, Μ. Stamouli1, I. Evmorfiadis1, I. Patsias1, V. Chatziantoniou1, Μ. Dadakaridou1, Ν. Tragomallos3, Μ. Aslanidou2, Ε. Sotiropoulou2, Μ. Kotsopoulou1, P. Repousis1, E. Megalakaki1 - Letter to the editor, journal of Balkan Union of Oncology:
“Castleman disease and adenocarcinoma” vol. 16, no. 4, 2011, pp 781-782, issue of J BUON
A. Megalakaki1, I. Evmorfiadis1, M. Stamouli1, N. Zakopoulou2, I. Iacovidou3 - Internal Medicine Days 2011, Athens, 15-16 April 2011:
New flu caused by H1N1: Clinical features in patients with haematologic diseases
E.Konstantinou1, Μ.Stamouli1, F.Katis1, G.Papageorgiou1, I.Evmorfiadis1, E.Lamprou2, V.Papaemmanouil2, Μ.Kotsopoulou1, P.Repousis1, E.Megalakaki1 - 21st Hellenic Haematology Congress, Thessaloniki, 10-12 November 2010:
DEFINING THE ACTIVITY OF MICROVESICLES IN PATIENTS WITH Ph(-) MYELOPROLIFERATIVE NEOPLASIAS
I. Patsias1, I. Evmorfiadis1, E. Kalagiakou1, A. Tsiampouris1, E. Samaridis1, G. Papadopoulos2, E. Kalouda1, L. Fountoulaki2, E. Manioudaki1, N. Laoutaris1 - 21st Hellenic Haematology Congress, Thessaloniki, 10-12 November 2010:
PLATELET FUNCTION STUDY IN PATIENTS WITH Ph(-) MYELOPROLIFERATIVE NEOPLASIAS. CORRELATION WITH THE MUTATED JAK-2 COPIES LOAD AND THE PRESENCE OF THROMBOTIC EPISODES
E. Kalagiakou1, I. Evmorfiadis1, A. Tsiambouris1, M. Chatzouli1, I. Patsias1, K. Vallianatou1, E. Sotiropoulou2, A. Zefkilis1, C Belessi1, L. Fountoulaki2, N. Laoutaris1, E. Manioudaki1 - 6th Hellenic Transfusion Therapy Congress, Ioannina 22-24 April 2010
CHARACTERISTICS OF REPLACEMENT BLOOD DONORS
Sotiropoulou E., Evmorfiadis I., Papadopoulos G., Fakitsa V., Stamoulis K., Fountoulaki-Paparizou L.
Transfusion Centre of G.H. of Nikea-Piraeus “Ag.Panteleimon” - 14th EHA Congress, June 4-7 2009, Berlin, Germany:
JAK2 V617 ALLELE BURDEN AND THROMBOSIS IN PATIENTS WITH POLYCYTHEMIA VERA AND ESSENTIAL THROMBOCYTHEMIA
E. Kalagiakou ,I. Evmorfiadis ,M. Hatzouli ,E. Manioudaki ,M. Kotsopoulou ,S. Malegkou ,K. Vallianatou ,I-D. Triantafyllopoulou ,E. Samaridis ,L. Dadiotis ,Ch. Mitsouli ,C. Belessi ,N. Laoutaris - 19th Hellenic Haematology Congress, Athens 19-22 November 2008
TREATING del 5q MYELODYSPLASTIC SYNDROMES WITH LOW DOSE LENALIDOMIDE
E. Manioudaki1, I. Evmorfiadis1,E. Kalagiakou1, K. Vallianatou1, E. Samaridis1, E. Nikolarou1, P. Pantoula2, G. Erotokritou1, A. Parasi2, K. Sampani3, N. Laoutaris1 - 19th Hellenic Haematology Congress, Athens 19-22 November 2008
LABORATORY AUTOMATION WITH SYSMEX AUTOMATED HAEMATOLOGIC ANALYSERS & THEIR FUNCTIONS IN CLINICAL PRACTICE
Nikolaos Laoutaris, Ilias Evmorfiadis - May 2008: Co-author of the book “The Diabetic Foot”
Medical Publications G.V. Pasisianou, Scientific Editor-Responsible for the publication: Dr. Dimitrios E. Vogiatzoglou - 13th Hellenic Internal Medicine Congress, Athens 8th -13th October 2007:
SYMPTOMATIC HYPOGLYCAEMIA & SELECTIVE SEROTONIN REUPTAKE INHIBITORS
Dimitrios Papavasiliou1, Vasiliki Dimakopoulou1, Evaggelos Rotas1, Sotirios Georgiou1, Ilias Evmorfiadis1, Evaggelos Neroutsos2, Konstantinos Christopoulos1, Dimitrios Vogiatzoglou1
1. 1st Pathologic Dept. G. H. Melissia “Amalia Fleming”, 2 Psychiatric Dept. G. H. Elefsina “Thriasio” - 3rd Hellenic Congress on Wound & Ulcers:
EXPERIENCE OF 9-YEAR FUNCTION OF DIABETIC FOOT STUDY-THERAPY PRACTICE. PATIENT’S CLINICAL CHARACTERISTICS
Evmorfiadis I, Volonakis S, Mitsouras K, Renieris I, Vogiatzoglou E, Karagiorgos P,
Vogiatzoglou D. - Switch in X-inactivation in a JAK2 V617F-negative case of polycythemia vera with two acquired X-autosome translocations.
Leukemia Research July 2007 (Vol. 31, Issue 7, Pages 1009-1014)
K. Manola, C. Stavropoulou, V. Georgakakos, K. Zoi, M. Fisfis, I. Evmorfiadis, C. Zoi, G. Pantelias, K. Stefanoudaki,
C.Sambani
